By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Using an array of technologies, researchers at the University of British Columbia, Cross Cancer Institute of Alberta, and Cancer Research UK have illustrated just how complex triple negative breast cancer tumors are and how their mutational patterns evolve throughout tumor progression.

The finding could help explain why this particular subtype of breast cancer is so good at resisting treatment, and could eventually lead to more effective therapies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.